Tag Archives: Outcomes

Prostate Medications May Develop Serious Side Effects As Per Outcomes Measurement Data While Natural Thermobalancing Therapy Is Harmless States Fine Treatment

August 07, 2012     No comments


London, UK (PRWEB) July 24, 2012

Men are likely to develop side effects while treating chronic prostatitis or enlarged prostate with long-term intake of antibiotics and medications, whereas the course of a new therapy with Dr. Allen?s device is totally harmless as it improves the blood circulation inside the prostate naturally, Fine Treatment reveals. Moreover, Dr. Allen?s Device for Prostate Care is able to treat chronic prostatitis and benign prostatic hyperplasia (BPH) up to full recovery.

Successful patients’ case studies confirm that Dr. Allen?s device provides exceptional prostate treatment. For instance, Sampath, 50, from India was trying to ease the symptoms of chronic prostatitis — such as high frequency of urination, burning sensation with discomfort while passing urine and the resultant erectile dysfunction — with pills and other treatment options unsuccessfully for 4 years. After 3-months of using Dr. Allen?s device, most of the symptoms were reduced by about 90%, and after following 2 months the prostatitis disorder was solved.

Another user of Dr. Allen?s device, Timo, 38, from Finland used to suffer from chronic prostatitis for quite a long time with front side pains and painful peeing urgency a few times a day. ?I am depressed because no medication helps?, wrote Timo before starting to wear the device. After 5 months of its use, he has stated: ?Not a problem with the prostate condition at a moment, since June, so I am not wearing the device any longer?.

According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), ?because drug treatment is not effective in all cases, researchers in recent years have developed a number of procedures that relieve BPH symptoms but are less invasive than conventional surgery.? Any surgical procedure, however, even a less invasive one, is highly likely to cause a number of undesirable side effects. So, Fine Treatment recommends resorting to any surgery only in critical situations. In other instances, the use of Dr. Allen?s natural device can be highly beneficial. Please watch a short video about its benefits: http://www.youtube.com/watch?v=a48bbQJQsdE.

?New Thermobalancing Therapy is a unique option for prostate treatment which improves the condition of the prostate gland with outstanding results,? says Dr. Allen. ?Dr. Allen?s therapeutic device is effective for exclusively prostate conditions, such as chronic prostatitis and BPH, as it treats the prostate locally.?

Dr. Allen?s Device for Prostate Care is easy to use. Read more at http://www.finetreatment.co.uk/prostatetreatmentbph/prostatitistreatment.html.

About Dr. Simon Allen and Fine Treatment:

Dr. Simon Allen is a highly experienced medical professional. His specialty is in the internal medicine and cardio-vascular field, and he has treated patients after a heart attack, with kidneys problems, including kidney stones disease, prostate and spine conditions. Fine Treatment exclusively offers Dr Allen?s devices for chronic prostatitis and BPH treatment, coronary heart disease, dissolving kidney stones, as well as lower back pain treatment and sciatica relief.







Find More Diabetes Press Releases

Read More

Experts to Share New Insights on Improving Autism Outcomes

July 05, 2012     No comments

Tyson’s Corner, Virginia (PRWEB) November 5, 2007

11th Annual Conference of the Interdisciplinary Council on Developmental and Learning Disorders to be held Nov. 9-11 . Leading experts on Autism Spectrum Disorders (ASD) and child development will discuss new advances in the screening, diagnosis, treatment, education, and family dynamics of autism and associated disorders, at a major conference on Nov. 9-11 at Tyson’s Corner, Virginia, outside Washington, D.C.

Speakers at the 11th Annual Conference of the Interdisciplinary Council on Developmental and Learning Disorders (ICDL) will unveil new screening tools for early detection, provide insights on how to read “red flags” that indicate risk factors for autism and related disorders, and report on successful intervention programs, including comprehensive treatment approaches to help children with autism learn communication skills.

More than 1,000 participants are currently registered for the conference, but spaces are still available, particularly for special pre- and post-conference workshops offered this year for parents and professionals.

The conference, titled “Critical Factors for Optimal Outcomes for Children with Autism and Special Needs,” will include panel discussions on a wide range of issues related to autism and related disorders and will feature researchers and clinicians in the areas of neuroscience, pediatric medicine, developmental psychology, mental health, communication and language development.

Plenary panels include:

. Improving Educational Outcomes

. Looking Inside the Brain and Mind as Autism Develops: Why Some Children Learn to Develop Creativity, Empathy and Abstract Thinking

. Earliest Indicators of ASD: The Do’s and Don’ts of Early Intervention

. New Understanding and Treatment of ADHD, OCD, Anxiety and Behavior Problems in Children with ASD

. The Stigma of Diagnosis

Speakers will include internationally renowned experts, including child psychiatrist Stanley Greenspan, pediatrician T. Berry Brazelton, and educator Howard Gardner, among others.”Hearing these international experts from different fields speak together in a panel about autism and special needs will be a once-in-a-lifetime opportunity,” said Serena Wieder, clinical psychologist and associate chair of ICDL. “They will share their experiences in improving educational outcomes for children with special needs and on the benefits of working with an interdisciplinary team to better understand this complex syndrome.”

The conference takes place amid growing concern about the increase in autism and related disorders in recent years. The Centers for Disease Control and Prevention (CDC) now estimates that 1 in 150 children in the United States have autism, a much higher rate than previously reported. Nearly 17 percent of U.S. children are diagnosed with developmental challenges that require early identification and preventive interventions, yet fewer than half are identified as having a problem before starting school. A new framework developed by the CDC and ICDL is aimed at identifying children at risk and facilitating early intervention and treatment, and will be presented at the conference.

As in past years, ICDL will offer pre-conference workshops on Thursday, Nov. 8, along with several new post-conference workshops designed to let participants delve more deeply into a range of topics raised during the conference, in areas including research, communication and language, sensory processing and regulation, parent interventions , and infant and early childhood mental health.

ICDL is a nonprofit organization dedicated to improving the prevention, assessment, diagnosis, and treatment of emotional and developmental disorders in infancy and childhood by promoting dialogue and integration knowledge form different disciplines. For more information, please visit http://www.icdl.com or contact Cecilia Breinbauer, M.D., M.P.H. at 301-656-2667.

###



Related OCD Press Releases

Read More

Increasing Investment in Stem Cell Technology and Promising Research Outcomes Drives the Stem Cell Research Market, According to New Report by Global Industry Analysts

May 12, 2012     No comments

San Jose, California (PRWEB) May 10, 2012

Follow us on LinkedIn ? Stem cell research is a promising area of biotechnology, which holds tremendous potential in rendering a new approach to the treatment of various degenerative diseases. The area deals with employing regenerative stem cells for the replenishment of damaged cells of a particular organ or tissue with new cells. These repair blocks have created a new specialty in the area of medicine called the regenerative medicine. Stem cells hold potential to treat conditions such as Alzheimer?s disease, Parkinson?s disease, stroke, spinal cord injury, heart disease, diabetes, burns, rheumatoid arthritis and osteoarthritis. In addition to its therapeutic applications, stem cells are also finding use in drug discovery, promising new avenues in the area of drug development. Growth in the research space is attributed to the acceptance of stem cell technology by patients for treating chronic diseases. Moreover advancement in stem cell research can help reduce the escalating healthcare costs associated with conventional methods of treatment.

Stem cell technology is still in a nascent stage. The market still lacks substantial data that could establish its long-term efficacy as well as safety. Certain issues pertaining to its administration have also raised concerns. The regulatory and ethical barriers across the world, particularly in Western countries, are the major challenges ahead of stem cells research. The barriers are particularly more in embryonic stem cell research. On the other hand, countries such as India, with comparatively less opposition, are better positioned to conduct stem cell research. Lack of proper funding is also a matter of concern for stem cell research. Countries, such as Thailand, Taiwan, Malaysia, Singapore, China, and India, are engaged in commercial, clinical, and scientific advancements in stem cell research without proper funding.

Over the past few years, the stem cells market has witnessed several breakthroughs that bodes tremendous potential in reshaping the area of medicine. Potential therapeutic applications of stem cells cut across several debilitating and deadly disease areas, including cancer and AIDS. Stem cell research is entering new avenues of medicine, and promises to provide a solution to combat diseases that were hitherto believed to be incurable. There is a growing demand for such therapies, which in turn provokes continued investments in the area, and foretell a remarkable growth in the industry in the coming years. Presently, the field is focused upon the treatment of certain oncological ailments, which include non-Hodgkin’s lymphoma, multiple myeloma, and leukaemia. Additionally, non-cancerous diseases, including lupus, immunodeficiency, and aplastic anaemia, are also being investigated for treatment using stem cell technology.

Mesenchymal stem cells and hematopoietic stem cells, extracted from adult bone marrow, are the leading types of adult stem cells currently in demand in the area of medicine. Of these types, hematopoietic stem cells hold major share in disease management. The dominance of hematopoietic stem cells is in part due to the difficulty associated with the isolation of mesenchymal from the bone marrow owing to availability of cells in lower levels. The greatest strength of adult stem cells is the presence of genomic stability of a very high degree. Additionally, stem cell therapy does not necessitate pre-treatment or genetic modification that is required when dealing with embryonic stem cells.

The US represents the largest regional market worldwide, as stated by the new market research report on Stem Cell Research. Despite the 9-year ban, which ended in 2009, over federal funding for research in embryonic stem cells, North America is presently dominating the stem cell market. Key factors that have kept North American market on the top of the charts include advanced stem cell research infrastructure and facilities, and federal support for the research. Asia is emerging as the fastest growing regional market for stem cell research worldwide with countries such as Japan, China, Singapore, Korea, and Australia evolving as major hubs for stem cell research.

Major players profiled in the report include Advanced Cell Technology Inc., Athersys Inc., Cytori Therapeutics Inc., Genzyme Corporation, Geron Corporation, International Stem Cell Corporation, Mesoblast Ltd., Osiris Therapeutics Inc., StemCells Inc., ThermoGenesis Corp., among others.

The research report titled ?Stem Cell Research: A Global Strategic Business Report? announced by Global Industry Analysts, Inc., provides comprehensive market overview, trends & issues, regulatory overview, overview on therapies under development, recent industry activity and profiles of market players worldwide. The report analyzes global adult stem cell research market in terms of annual investments in value for the years 2008 through 2017, for major geographic markets, including the US, Europe and Rest of World.

For more details about this comprehensive market research report, please visit ?

http://www.strategyr.com/Stem_Cell_Research_Market_Report.asp

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world’s largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.

Telephone: 408-528-9966

Fax: 408-528-9977

Email: press(at)StrategyR(dot)com

Web Site: http://www.StrategyR.com/

###







Read More

Dr. Kenneth Light: Spinal Disc Implants, Fusion Reversal & Stenosis Treatment Improve Outcomes

May 02, 2012     No comments

San Francisco, CA (PRWEB) August 03, 2011

Just a decade ago, the options for treating back pain and injuries were more limited, says San Francisco spine surgeon Dr. Kenneth Light. ?For example, spinal fusions have been and continue to be a first choice among many spine surgeons to repair injuries and to address pain,? says Dr. Light.

?A spinal fusion procedure is routinely performed to address unstable vertebrae – spines that were slipping in various directions, or spines that were crooked, such as in scoliosis, to straighten and place the vertebra back into alignment,? says Dr. Light. ?Spinal fusions are still appropriate for those conditions,? says Dr. Light. ?The main disadvantage is that a spinal fusion makes the back abnormally stiff and unable to function as it normally would.?

Dr. Light, who recently performed the first spinal fusion reversal procedures on two women from the San Francisco area says spinal disc implants may be an attractive alternative for for many patients, and an option for those who still experience pain after undergoing a spinal fusion procedure.

?Spinal disc implants were developed in Europe about 20 years ago and the results were very good,? says Dr. Light. ?But it wasn’t until about six or seven years ago that they were finally approved for use in the United States by the F.D.A . I believe that spinal disc replacement is the single greatest advancement in spinal surgery in the past 50 years,? says Dr. Light. ?Spinal disc implants also allow for a nearer to normal range of motion, which can considerably improve a person?s quality of life,? he says.

Spinal stenosis – start with a correct diagnosis.

?With the aging population, more people are having difficulty walking,? says Dr. Light – ?There are 3 reasons why people over the age of sixty have problems walking: hip arthritis, arteriosclerosis, and spinal stenosis. All 3 conditions can present the same symptoms, so you could have hip surgery when you actually need stenosis treatment, for example?? says Dr. Light. ?The right diagnosis is essential, which is why it?s important to seek a qualified orthopaedic surgeon who can determine what is causing the symptoms.?

For additional information visit http://www.drkennethlight.com or call 415.673.4500.

Media inquiries, contact Gary Grasso, Director, Doctor’s P.R. Medical News: http://www.doctorspr.com or call 626.222.7955.

Dr. Kenneth Light graduated from the Cornell University College of Medicine in New York City. He completed his residency in Orhopaedic Surgery at the University of California in San Francisco., and completed a fellowship in spinal surgery under the guidance of Edward H. Simmons at the State University of New York in Buffalo.

Dr. Light was director of the spine clinic at San Francisco General Hospital, and was founder and medical director of the San Francisco Spine Center at Saint Francis Memorial Hospital. He is a fellow of the American Academy of Orthopedic Surgery, is board certified with the American Board of Orthopedic Surgery and Assistant Clinical Professor of Orthopedic Surgery at University of California, San Francisco. He is currently in private practice in San Francisco where he specializes in reconstructive surgery in patients who have had failed back surgery.

###



Read More
Powered by WordPress | Designed by: best suv | Thanks to toyota suv, infiniti suv and lexus suv